Results 1 to 5 of 8
Most popular |Most recent

The No Surprises Act: Implications for Health Plans, Health Care Facilities, and Health Care Providers

USA - January 19 2021 Helaine I. Fingold, Jonah D. Retzinger, Alexis Boaz Following months of congressional negotiations, on December 27, 2020, President Trump signed into…

Helaine I. Fingold, Jonah D. Retzinger.

Finalized HHS Drug Formulary Rebate Rule Faces Uncertain Future Under Biden Administration and Current Legal Challenge

USA - January 15 2021 On November 30, 2020, the U.S. Department of Health and Human Services (“HHS”) Office of Inspector General (“OIG”) published a final rule (“Final…

Alan J. Arville, Christopher R. Smith, Constance A. Wilkinson, John S. Linehan.

False Claims Act Enforcement During the COVID-19 Pandemic and Beyond

USA - August 28 2020 Earlier this summer, Ethan P. Davis, Principal Deputy Assistant Attorney General for the Civil Division of the U.S. Department of Justice (DOJ)…

George B. Breen.

President Trump Signs Executive Orders on Drug Pricing and Domestic Supply Chain Reform

USA - August 21 2020 On August 6, 2020, President Donald Trump signed an Executive Order directing federal agencies to increase domestic procurement and identify supply…

Alan J. Arville, Christopher R. Smith, Constance A. Wilkinson, Jennifer E. Michael, John S. Linehan.

New and Pre-Existing Federal Waivers and Flexibilities Available to Health Care Providers During a National Emergency

USA - March 20 2020 In response to the 2019 novel coronavirus (“COVID-19”) pandemic, one of Congress’s first actions was the passage of emergency supplemental…

Helaine I. Fingold, Lesley R. Yeung, Philo D. Hall.